Our Take Dutch cyclists figured out the stroopwafel centuries ago
Increasing awareness of diabetes and obesity, coupled with rising disposable incomes and government initiatives to improve chronic disease management, are key factors driving the significant growth potential of the GLP-1 receptor agonist market in the Asia Pacific region
Interestingly, in preclinical studies, a potential anti-tumor role has been evidenced for tetrathiomolybdate, the molybdenum form used to treat Wilson disease, due to its copper-chelating ability
Many telehealth platforms exploit this medical requirement by charging a low introductory price (e.g., $199/mo) that only covers the initiation doses (0.25 mg and 0.5 mg)
Many patients admitted for acute myocardial infarction have type 2 diabetes, and they are more likely to die during the acute episode or in follow-up [1]
Exenatide BID demonstrated similar HbA1c improvement as insulin glargine over 26 weeks (1.25% vs 1.26%) but led to weight loss rather than weight gain of 3 kg with insulin